Video

CORAL Study Brings Positive News for Adults With Depression

Coadministration of zuranolone with a standard antidepressant yields positive outcomes.

Sagar Parikh, MD, FRCPC, shares news about the CORAL Study examining zuranolone treatment in patients with major depressive disorder, which demonstrated a rapid and statistically significant reduction in depressive symptoms at day 3 and over the 2-week treatment period.

To read more about this study, see: Improving Depression Symptoms: Study Meets Endpoints.

Dr Parikh is a professor of Depression and Clinical Neuroscience, and Psychiatry Sciences, at the University of Michigan.

Related Videos
depression
brain depression
brain
depression obesity
summer sadness
Experts on MDD.
Experts on MDD.
depression
© 2024 MJH Life Sciences

All rights reserved.